The infant aphakia treatment study: design and clinical measures at enrollment. - Wikidata - awgldk - TriplyDB

The infant aphakia treatment study: design and clinical measures at enrollment.

The infant aphakia treatment study: design and clinical measures at enrollment.

http://www.wikidata.org/entity/Q34317163

about

Evaluating the evidence for and against the use of IOLs in infants and young children The Infant Aphakia Treatment Study: evaluation of cataract morphology in eyes with monocular cataracts A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year.The effects of surgical factors on postoperative astigmatism in patients enrolled in the Infant Aphakia Treatment Study (IATS).Association Between Occlusion Therapy and Optotype Visual Acuity in Children Using Data From the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.The role of preoperative biometry in selecting initial contact lens power in the Infant Aphakia Treatment Study.Myopic Shift 5 Years after Intraocular Lens Implantation in the Infant Aphakia Treatment Study.Globe Axial Length Growth at Age 5 Years in the Infant Aphakia Treatment Study.Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study Stereopsis results at 4.5 years of age in the infant aphakia treatment study.Baseline characteristics of the infant aphakia treatment study population: predicting recognition acuity at 4.5 years of age Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery in the infant aphakia treatment study at age 5 years Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study.Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study.Predictors of adherence to occlusion therapy 3 months after cataract extraction in the Infant Aphakia Treatment Study.Selection of an initial contact lens power for infantile cataract surgery without primary intraocular lens implantation.One-year strabismus outcomes in the Infant Aphakia Treatment Study.Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study.Adherence to occlusion therapy in the first six months of follow-up and visual acuity among participants in the Infant Aphakia Treatment Study (IATS).The infant aphakia treatment study contact lens experience: one-year outcomes.Nystagmus and related fixation instabilities following extraction of unilateral infantile cataract in the Infant Aphakia Treatment Study (IATS).Corneal Changes in Children after Unilateral Cataract Surgery in the Infant Aphakia Treatment Study.Axial elongation following cataract surgery during the first year of life in the infant Aphakia Treatment Study.Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery: retrospective analysis at age 1 year.Prevalence of Corneal Astigmatism and Anterior Segmental Biometry Characteristics Before Surgery in Chinese Congenital Cataract Patients.Distribution of Axial Length before Cataract Surgery in Chinese Pediatric Patients.Parenting stress in the infant aphakia treatment study.Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS).Motor skills of children with unilateral visual impairment in the Infant Aphakia Treatment Study.Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results.The Infant Aphakia Treatment Study: further on intra- and postoperative complications in the intraocular lens group Functional outcome measures for NF1-associated optic pathway glioma clinical trials.Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas.Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research.Complications of pediatric cataract surgery.Iris-fixated intraocular lenses for ametropia and aphakia.

P2860

Q28069418-A894E47A-3E51-4D30-BF0B-943BE09B9F33 Q30513961-31588A00-1834-446F-BA87-B78ACDD7509F Q30528885-D32CBF93-8980-4121-A5E2-24AF8402E696 Q30662295-D3AEFA72-2F53-4CA0-A67E-24AAA76B8F4A Q31102382-0623C89D-E9BA-4F44-8279-B215CA7A01F9 Q33842498-CFC93864-825F-47D5-8C0F-B34E1E9497E4 Q33898801-87726654-3895-47E5-94AD-09962CF254DB Q33906772-B7F06D31-1AD3-4BD4-8A53-9E39D8F9F23C Q34069081-6F5802BE-38BE-41AA-B1E8-EA3277766BC3 Q34074324-F9AB1AC8-3B77-4469-AA0C-328369E46F2E Q34674031-E44EEA98-EB60-47C6-8170-378778DE2DF0 Q34976929-AA7374C3-7114-4863-B2E8-F64BC679CB2C Q35014085-EE8C6C05-5192-4198-B3B2-DC66A94EBA29 Q35571131-4B5A2FAD-E372-4178-AA27-25BB1A4974FE Q35592817-9AAC5AAC-C6D1-4883-96B3-236CA33742EE Q35652582-4A8EF385-01FD-456C-85A4-D4F14E8CCBB6 Q35897086-9780196F-9EEE-48D8-95F7-857A082F5E07 Q35911750-ADE547C6-17DE-49EA-8CC8-AB86C5161973 Q35915225-52EF978B-1E4A-43F3-990E-4C38F16BB03A Q35917984-E8E20606-D532-4737-9C50-14125D0009F9 Q35991316-4F70C333-2228-4DC2-AB8A-2B5CF54263CD Q35991346-AC71E201-4760-4AAE-B3F2-3B04099F6A93 Q36030041-DED1895D-6246-4B80-B917-7C9B48A0F702 Q36066937-6F5638DC-3588-42E3-9D0D-E9C9AD28FF3A Q36086388-1CE5DDD2-E63E-4018-A8A5-510AFA9EC86D Q36218160-2960A6B3-278E-4F25-A94E-6E8597638944 Q36383634-CAAA333D-939A-4749-8119-B6414A13499C Q36508266-6B18DC63-0D00-4A2F-8E18-66636AA81914 Q36616036-A25B1C87-287A-45C8-8CC9-C53C8C2C3EE6 Q36736339-EF444621-7F83-4DDC-B291-1042771FDD1C Q36882403-A8A28E27-FEC6-4EF2-8BAE-95A331ED9B37 Q36908898-BCCC9EEB-C878-47CB-A716-74E19F4F1FF3 Q36908963-5EFC56CE-9960-4A31-91CD-2E4049D0BB3C Q37013023-CA91EC90-C789-4A5F-B83D-453AC794E888 Q37052868-E8D4251A-CC01-44D6-9C68-C87793896317 Q37536287-FBC489AC-2EEB-4295-8EBE-C161A58EF922 Q37636893-50F3A9A8-7090-4ACE-97F1-3E0B888D257A Q38030473-C4559E6A-0F5B-4D83-8D64-FB4DFBCB6011 Q38261121-378D9A5E-CD76-4EC5-A3E1-39B9664A07E9 Q38371765-D27F479F-F620-46D2-8315-0C86DCB322A2

P2860

The infant aphakia treatment study: design and clinical measures at enrollment.

http://www.wikidata.org/entity/Q34317163

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The infant aphakia treatment study: design and clinical measures at enrollment.

@ast

The infant aphakia treatment study: design and clinical measures at enrollment.

@en

The infant aphakia treatment study: design and clinical measures at enrollment.

@nl

type

label

The infant aphakia treatment study: design and clinical measures at enrollment.

@ast

The infant aphakia treatment study: design and clinical measures at enrollment.

@en

The infant aphakia treatment study: design and clinical measures at enrollment.

@nl

prefLabel

The infant aphakia treatment study: design and clinical measures at enrollment.

@ast

The infant aphakia treatment study: design and clinical measures at enrollment.

@en

The infant aphakia treatment study: design and clinical measures at enrollment.

@nl

P1433

Q34317163-CA78742E-7848-4BCA-BF00-78CC2CD0DE85

P1476

Q34317163-A8D4A207-7A01-449E-95FD-B5F08C479515

P2093

Q34317163-05CAC65D-39C4-4EEC-85C8-E068A0C7A5F6

Q34317163-4102BA19-4E56-488E-8042-09F32B9E65E9

Q34317163-567E7FC3-E9BA-4C54-9436-9C1CAB8379AC

Q34317163-78759490-FF07-445C-A318-757F623EC21F

Q34317163-7FF7A083-85B6-443B-A1D1-70D4D492E222

Q34317163-ADB443D9-FB0E-421E-8096-92AF5418C398

Q34317163-B2FEBC52-11FB-4047-A0D5-8C4462B52DB6

Q34317163-C4274693-D705-420F-BB6C-F4C2490B3513

Q34317163-CB461F60-E879-499D-AB8D-597177049EE4

P2860

Q34317163-1283EF62-F70A-411E-B091-3B052B6D3F9F

Q34317163-191D63BB-85EA-4C5A-B9B0-E4690033D7EF

Q34317163-268B5004-8F8F-4868-B451-39E144785506

Q34317163-29DC71FD-42E1-4135-9764-1B880B19A6F1

Q34317163-44E88198-62A4-42BE-A360-C42785191030

Q34317163-4BF53489-CD83-4DFB-9871-764758C0F784

Q34317163-5C139A29-55AB-400D-A0F9-EBEFB372E505

Q34317163-722B9520-76A7-4AFC-9949-C62D3D13AA88

Q34317163-8C2261C3-4655-4EC6-B9C2-98928EF543D9

Q34317163-93CB5514-4A20-42E6-84E1-E7EC8BA83E95

P304

Q34317163-F5307A6C-0B26-4FB4-98F9-94BA61FE2DC9

P31

Q34317163-9ADA7ECC-91D8-4AC4-AA6B-25DE61BC9118

P356

Q34317163-BC9D3B55-C94C-424C-B3F6-54B4718336E3

P407

Q34317163-92FF405F-9063-427A-9B6C-4DA0E115918F

P433

Q34317163-0B205309-93B2-402F-92CE-65CFDA929BE7

P478

Q34317163-CE8792CC-69BD-42D7-8E58-6C42EFEA5D2F

P577

Q34317163-D6760FA4-295A-4F10-9AB7-6D839865FE0D

P5875

Q34317163-0FF45308-3287-44CB-9D6C-FD76478CEBE4

P698

Q34317163-2E94A0B7-D07A-47A3-84A4-E2401001253E

P921

Q34317163-AAE654BF-2AD6-45E7-A718-C6B4A339105F

P932

Q34317163-9CD54C0B-52E9-4DF6-B8A9-DBF59B6DBD5F

P356

ARCHOPHTHALMOL.2009.350

P1433

JAMA Ophthalmology

P1476

The infant aphakia treatment study: design and clinical measures at enrollment.

@en

P2093

Carolyn Drews-Botsch

http://www.w3.org/2001/XMLSchema#string

David A Plager

http://www.w3.org/2001/XMLSchema#string

Edward G Buckley

http://www.w3.org/2001/XMLSchema#string

Eugenie Hartmann

http://www.w3.org/2001/XMLSchema#string

Infant Aphakia Treatment Study Group

http://www.w3.org/2001/XMLSchema#string

Lindreth DuBois

http://www.w3.org/2001/XMLSchema#string

M Edward Wilson

http://www.w3.org/2001/XMLSchema#string

Michael J Lynn

http://www.w3.org/2001/XMLSchema#string

Scott R Lambert

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the amblyopia treatment study HOTV and the electronic-early treatment of diabetic retinopathy study visual acuity protocols in amblyopic children aged 5 to 11 years

Use of AcrySof acrylic foldable intraocular lens for secondary implantation in children.

Is early surgery for congenital cataract a risk factor for glaucoma?

Paediatric pseudophakia: analysis of intraocular lens power and myopic shift.

ASCRS white paper. Hydrophobic acrylic intraocular lenses in children.

Compliance in amblyopia therapy: objective monitoring of occlusion.

Visual outcome following the reduction or cessation of patching therapy after early unilateral cataract surgery.

Modulation of amblyopia therapy following early surgery for unilateral congenital cataracts.

Epidemiology of cataract in childhood: a global perspective.

Theoretic refractive changes after lens implantation in childhood.

P304

21-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHTHALMOL.2009.350

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40907799

http://www.w3.org/2001/XMLSchema#string

P698

20065212

http://www.w3.org/2001/XMLSchema#string

P921

P932

2983098

http://www.w3.org/2001/XMLSchema#string